Hepatic Cell News Volume 7.40 | Oct 27 2023

    0
    23








    2023-10-27 | HCN 7.40


    Hepatic Cell News by STEMCELL Technologies
    Vol. 7.40 – 27 October, 2023
    TOP STORY

    Gut Insulin Action Protects from Hepatocarcinogenesis in Diabetic Mice Comorbid with Nonalcoholic Steatohepatitis

    Using a STelic Animal Model, investigators treated male mice, which developed diabetes, nonalcoholic steatohepatitis, and HCC associated with dysbiosis upon low-dose streptozotocin and high-fat diet, with insulin or phlorizin.
    [Nature Communications]

    Full Article
    Request a free copy of the Growing Organoids from Stem Cells Wallchart
    PUBLICATIONSRanked by the impact factor of the journal

    RING Finger Protein 13 Protects against Nonalcoholic Steatohepatitis by Targeting STING-Relayed Signaling Pathways

    A phenotype-based high-content screening was performed and RING finger protein 13 (RNF13) was identified as an effective inhibitor of lipid accumulation in vitro.
    [Nature Communications]

    Full Article

    A CRISPR/Cas9 Library Screening Identifies CARM1 as a Critical Inhibitor of Ferroptosis in Hepatocellular Carcinoma Cells

    Scientists conducted a CRISPR/Cas9 library screening targeting epigenetic factors and identified coactivator-associated arginine methyltransferase 1 (CARM1) as a critical inhibitor of ferroptosis.
    [Molecular Therapy – Nucleic Acids]

    AbstractFull ArticleGraphical Abstract

    Nuclear Respiratory Factor 1 Drives Hepatocellular Carcinoma Progression by Activating LPCAT1-ERK1/2-CREB Axis

    The authors explored the role of nuclear respiratory factor 1 in HCC progression and investigated the underlying mechanisms.
    [Biology Direct]

    Full Article

    ZNF281 Inhibits Mitochondrial Biogenesis to Facilitate Metastasis of Hepatocellular Carcinoma

    Zinc finger protein 281 (ZNF281) knockdown increased the expression of mitochondrial transcription factor A in HCC cells, accompanied by an increment of mitochondrial content, oxygen consumption rate, and levels of tricarboxylic acid cycle intermetabolites.
    [Cell Death Discovery]

    Full Article

    GPC3-IL7-CCL19-CAR-T Primes Immune Microenvironment Reconstitution for Hepatocellular Carcinoma Therapy

    Investigators engineered a novel GPC3-targeting CAR including an anti-GPC3 scFv, CD3ζ, CD28, and 4-1BB that induced co-expression of IL-7 at a moderate level and CCL19 at a high level, and transduced it into human T cells.
    [Cell Biology and Toxicology]

    AbstractGraphical Abstract

    KHDRBS3 Accelerates Glycolysis and Promotes Malignancy of Hepatocellular Carcinoma via Upregulating 14-3-3ζ

    KH domain-containing, RNA-binding signal transduction-associated protein 3 (KHDRBS3) knockdown and overexpression were performed using the lentiviral vector system to investigate the effects of KHDRBS3 on cell proliferation, apoptosis, chemoresistance, and glycolysis.
    [Cancer Cell International]

    Full Article

    ABHD12 Contributes to Tumorigenesis and Sorafenib Resistance by Preventing Ferroptosis in Hepatocellular Carcinoma

    Researchers used a comprehensive approach to investigate the effects of ABHD12, which regulated tumorigenesis and sorafenib resistance in liver hepatocellular carcinoma.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    Cancer Development in Hepatocytes by Long-Term Induction of Hypoxic Hepatocellular Carcinoma Cell (HCC)-Derived Exosomes In Vivo and In Vitro

    Hypoxic HCC cell-derived exosomes (H-LM3-exos) were used to induce hepatocytes over the long term. A nude mouse experiment further verified the effect of H-LM3-exos on tumor growth and metastasis.
    [Molecular Pharmaceutics]

    AbstractGraphical Abstract
    Learn how to stay motivated in research.
    REVIEWS

    Inflammatory Signaling in NASH Driven by Hepatocyte Mitochondrial Dysfunctions

    The authors consider the role of impaired mitochondrial function caused by lipotoxicity during oxidative stress in hepatocytes.
    [Journal of Translational Medicine]

    Full Article

    Hepatocellular Carcinoma: Up-Regulated Circular RNAs Which Mediate Efficacy in Preclinical In Vivo Models

    Scientists provide an overview of up-regulated circular RNAs that mediate efficacy in preclinical in vivo models of HCC.
    [Cancer Genomics & Proteomics]

    Full Article
    INDUSTRY AND POLICY NEWS

    First Detailed US Scientific Integrity Draft Policies Get Mixed Responses

    Keep working on it. That’s the reaction of US science watchdog groups to the first attempts by federal health agencies to flesh out a promise by President Joe Biden to restore trust in government by ensuring that government scientists are free to do their jobs without political meddling.
    [ScienceInsider]

    Press Release
    FEATURED EVENT

    Cell Therapy for Autoimmune Disease Summit

    November 28 – 30, 2023
    Philadelphia, Pennsylvania, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scientist – Cancer Research Cluster

    Cedars-Sinai – Los Angeles, California, United States

    Postdoctoral Research Scientist – Integrative Modeling

    CRUK Beatson Institute for Cancer Research – Glasgow, Scotland, United Kingdom

    Postdoctoral Fellow – Bioinformatics

    The University of Hong Kong – Hong Kong, Hong Kong

    Director – Center of Emphasis in Diabetes and Metabolism

    Texas Tech University Health Sciences Center El Paso – El Paso, Texas, United States

    Research Assistant – Hepatitis Research

    National University of Singapore – Singapore, Singapore

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter